SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001694187-19-000030
Filing Date
2019-04-26
Accepted
2019-04-26 08:55:51
Documents
5
Period of Report
2019-04-26
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A ntgn2019proxystatement.htm DEF 14A 489024
2 hodsignature.jpg GRAPHIC 10024
3 neonlogo.jpg GRAPHIC 13872
4 proxycardpage1.gif GRAPHIC 58340
5 proxycardpage2.gif GRAPHIC 40843
  Complete submission text file 0001694187-19-000030.txt   660082
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Filer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38551 | Film No.: 19769531
SIC: 2836 Biological Products, (No Diagnostic Substances)